Skip to main content
Veterinary Medicines

ZINGUL AD3E

Authorised
  • Retinol palmitate
  • Colecalciferol
  • TOCOPHERYL ACETATE

Product identification

Medicine name:
ZINGUL AD3E
Active substance:
  • Retinol palmitate
  • Colecalciferol
  • TOCOPHERYL ACETATE
Target species:
  • Horse
  • Cattle
  • Sheep
  • Goat
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Retinol palmitate
    50000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    25000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • TOCOPHERYL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        231
        day
    • Cattle
      • Meat and offal
        231
        day
    • Sheep
      • Meat and offal
        200
        day
      • Meat and offal
        200
        day
    • Goat
    • Pig
      • Meat and offal
        206
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11AB
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Provet S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Provet S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 220119
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 27/07/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."